Zydus Lifesciences
ZYDUSLIFE · Pharma > Pharmaceuticals & Drugs · Chairman: Pankaj R Patel · MD: Sharvil P Patel · Listing date: April 28, 2000 · Employees: 24412 · Ahmedabad · http://www.zyduscadila.com

Stock Price vs Company Growth
1d
1.1%
1w
5.1%
1m
1.9%
3m
7.7%
6m
23.6%
1y
13.6%
5y
16.3%
10y
12.7%
all
18.5%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 1,120 1.1%
1,029
1,206
Company Overview

Sales
28,592 Cr
Growth: 16.9%
Profit after Tax
4,513 Cr
Growth: -10.5%
Large Cap
1,11,691 Cr
P/E: 25.0x
Industry P/E: 31.7x
Fundamentals

Sales (Cr) ₹ 28,592
Growth 16.9%
EBITDA 25.4%
P/S 3.9x
Dividend 1.1%
P/E 25.0x
Book Value ₹ 281
PEG Ratio 1.5x
ROE 16.5%
P/B 4.0x
Shareholding Pattern

Institutions
Life Insurance Corporation Of India
3.63 %
Kotak Flexicap Fund
2.28 %
Government Pension Fund Global
1.15 %
Iepf
0.12 %
Llp
0.07 %
Promoters
Zydus Family Trust
74.86 %
Others
Increase    Decrease    No change
Company Profile Detailed

The company is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain of innovating (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), active pharmaceutical ingredients (APIs), animal healthcare products and consumer wellness products.
Investors (136)
Followers (34)